Research Paper Volume 14, Issue 19 pp 7866—7876

Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma

class="figure-viewer-img"

Figure 5. Construction and performance validation of the DTYMK based nomogram for lung adenocarcinoma patients. Nomogram to predict the (A) overall survival, (B) disease-specific survival, and (C) progression-free survival for lung cancer patients. The calibration curve and Hosmer–Lemeshow test of nomograms in the TCGA- lung adenocarcinoma cohort for (D) overall survival, (E) disease-specific survival and (F) progression-free survival.